Generic drug
Clindamycin price, strengths & recalls
Generic of Cleocin, Clindacin, Clindesse, Xaciato
Pharmacies pay $5.36 for 30 capsules of Clindamycin 300 mg capsule this week, and from $3.14 to $271.89 across its 10 priced strengths and forms. 52 manufacturers make it. It is in shortage (unavailable). 13 recalls are ongoing. Its official label last changed on July 10, 2026.
Unavailable13 open recallsGeneric- Fair cash price
- $16.66
- Strengths
- 10
- Makers
- 52
- Updated
- Nov 11
Clindamycin price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 75 mg capsule | $0.2692 | $8.08 / 30 capsules | ||
| 150 mg capsule | $0.1048 | $3.14 / 30 capsules | ||
| 300 mg capsule | $0.1786 | $5.36 / 30 capsules | ||
| 0.01 mg/mg gel | $0.1362 | $8.17 / 60 g | ||
| 0.01 mg/mg gel | $3.63 | $271.89 / 75 mL | ||
| 150 mg/mL injection | Not priced this week | |||
| 150 mg/mL, 2 mL injection | Not priced this week | |||
| 150 mg/mL, 4 mL injection | Not priced this week | |||
| 150 mg/mL, 6 mL injection | Not priced this week | |||
| 10 mg/mL lotion | $0.2323 | $13.94 / 60 mL | ||
| 15 mg/mL oral solution | $0.1328 | $13.28 / 100 mL | ||
| 10 mg/mL topical foam | $1.78 | $89.22 / 50 g | ||
| 10 mg/mL topical solution | $0.1892 | $11.35 / 60 mL | ||
| 20 mg/mL vaginal cream | $1.87 | $74.65 / 40 g | ||
The lowest cost per capsule is 150 mg capsule at $0.1048. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of clindamycin
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Civica Label
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Civica Label
- Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)
- Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
- Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)Selling through remaining short-dated inventory (Dec 2026).
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)Discontinuation of the manufacture of the drug
- Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)Selling through remaining short-dated inventory (Dec 2026).
- Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)Estimated recovery: January 2027
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 49 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Clindamycin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
Clindamycin Hydrochloride Capsules, USP
WARNING
Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including clindamycin hydrochloride and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon, leading to overgrowth of
C. difficile.
Because clindamycin hydrochloride therapy has been associated with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate, as described in the
INDICATIONS AND USAGE section. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections.
C. difficileproduces toxins A and B, which contribute to the development of CDAD. Hypertoxin producing strains of
C. difficilecause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial drug use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.
If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against
C. difficilemay need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial drug treatment of
C. difficile, and surgical evaluation should be instituted as clinically indicated.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA050615 · Pfizer
- First approved
- January 7, 1987 (39 years ago)
- Latest approved change
- November 12, 2025
- Approved label
- PDF, Nov 13, 2025
- Generic makers
- 42 approved generic applications on the market
Clindamycin questions
How much does clindamycin cost without insurance?
Pharmacies pay about $5.36 for 30 capsules of clindamycin 300 mg capsule ($0.1786 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $16.66. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of clindamycin?
Is clindamycin in shortage?
Yes. 27 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has clindamycin been recalled?
49 recalls on record, 13 ongoing. Recalls name specific lots - check yours.
When did the clindamycin label last change?
The official label was last updated on July 10, 2026 (version 22). See what changed.
Talk about clindamycin
No comments yet. Questions, tips, what worked for you - start the conversation.